Occudo Quantitative Strategies LP Xeris Biopharma Holdings, Inc. Transaction History
Occudo Quantitative Strategies LP
- $810 Million
- Q2 2025
A detailed history of Occudo Quantitative Strategies LP transactions in Xeris Biopharma Holdings, Inc. stock. As of the latest transaction made, Occudo Quantitative Strategies LP holds 179,354 shares of XERS stock, worth $1.66 Million. This represents 0.1% of its overall portfolio holdings.
Number of Shares
179,354
Previous 120,424
48.94%
Holding current value
$1.66 Million
Previous $661,000
26.63%
% of portfolio
0.1%
Previous 0.09%
Shares
5 transactions
Others Institutions Holding XERS
# of Institutions
212Shares Held
90MCall Options Held
81.6KPut Options Held
57.6K-
Black Rock Inc. New York, NY10.3MShares$95.5 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA9.82MShares$90.7 Million0.0% of portfolio
-
D. E. Shaw & Co., Inc. New York, NY3.84MShares$35.4 Million0.01% of portfolio
-
State Street Corp Boston, MA3.78MShares$35 Million0.0% of portfolio
-
Geode Capital Management, LLC Boston, MA3.65MShares$33.7 Million0.0% of portfolio
About Xeris Biopharma Holdings, Inc.
- Ticker XERS
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 135,956,992
- Market Cap $1.26B
- Description
- Xeris Biopharma Holdings, Inc., a biopharmaceutical company, engages in developing and commercializing therapies for patient populations in endocrinology, neurology, and gastroenterology. The company markets Gvoke, a ready-to-use liquid glucagon for the treatment of severe hypoglycemia; and Keveyis, a therapy for the treatment of hyperkalemic, h...